| Under the Dietary Supplement Health and Education | | | | stroke, hepatitis, seizure, psychosis, and even death. |
| Act of 1994 (DSHEA), manufacturers of nutritional | | | | For more information on other potentially dangerous |
| supplements are responsible for ensuring that their | | | | dietary supplements, you can visit the FDA website. |
| products are safe before they are marketed. | | | | 2. Product information |
| Manufacturers of nutritional supplements do not need | | | | FDA regulation of nutritional supplements also |
| to provide information to the Food and Drug | | | | includes, to an extent, the monitoring of the |
| Administration Board, before they can get a product | | | | truthfulness of label claims. FDA regulation of |
| out on the market. They also do not need the | | | | nutritional supplements requires that the labels of |
| board's review and approval of the supplement's | | | | dietary supplements include the statement of |
| ingredients before selling these products. | | | | identity, the net quantity of contents, the |
| FDA regulation of nutritional supplements is different | | | | structure-function claim: "This statement has not |
| from those covering "conventional" foods and drug | | | | been evaluated by the Food and Drug Administration. |
| products; it takes on a post-marketing responsibility | | | | This product is not intended to diagnose, treat, cure, |
| by way of monitoring safety and product information. | | | | or prevent any disease," the directions for use, the |
| 1. Monitoring safety | | | | Supplement Facts panel (includes serving size, |
| FDA regulation of nutritional supplements involves | | | | amount, and active ingredient), the other ingredients |
| monitoring the safety of a supplement product that | | | | in descending order of predominance and by common |
| is out on the market. Before the FDA can take | | | | name or proprietary blend, the name and place of |
| action to restrict the use of a nutritional supplement, | | | | business of manufacturer, packer or distributor, and |
| it has to show the hazards associated with the use | | | | the address to write to for more product |
| of the said nutritional supplement. | | | | information. |
| FDA regulation of nutritional supplements can be | | | | 3. Best practices |
| initiated in the form of studies, reviews, reports, | | | | FDA regulation of nutritional supplements also includes |
| scientific literature, and public comments. This was | | | | establishing good manufacturing practices, or GMPs, |
| what happened in 1997, when the FDA proposed to | | | | for manufacturers of nutritional supplements. To be |
| limit the amount of ephedrine alkaloids (also known as | | | | sure that the ingredients packed inside the marketed |
| ephedra, Chinese ephedra, Ma huang, and epitonin) in | | | | nutritional supplement product are the right |
| dietary supplements, as it was found to cause a | | | | ingredients and amount, choose a manufacturer that |
| range of side effects such as dizziness, nervousness, | | | | is GMP-compliant. |
| changes in heart rate and blood pressure, chest pain, | | | | |